SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-120266
Filing Date
2022-11-18
Accepted
2022-11-18 15:59:50
Documents
14
Period of Report
2022-11-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230989d1_8k.htm   iXBRL 8-K 31436
2 EXHIBIT 99.1 tm2230989d1_ex99-1.htm EX-99.1 13689
3 GRAPHIC tm2230989d1_ex99-1img001.jpg GRAPHIC 2792
  Complete submission text file 0001104659-22-120266.txt   225652

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA avdl-20221118.xsd EX-101.SCH 3085
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20221118_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20221118_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2230989d1_8k_htm.xml XML 3477
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 221401863
SIC: 2834 Pharmaceutical Preparations